CN Patent

CN101495468A — 血浆激肽释放酶抑制剂

Assigned to Activesite Pharmaceuticals Inc · Expires 2009-07-29 · 17y expired

What this patent protects

本发明提供了能够抑制血浆激肽释放酶(PK)活性的化合物以及在PK依赖性疾病或病症期间或之后预防和治疗血栓形成的方法，例如在纤维蛋白溶解治疗之后。

USPTO Abstract

本发明提供了能够抑制血浆激肽释放酶(PK)活性的化合物以及在PK依赖性疾病或病症期间或之后预防和治疗血栓形成的方法，例如在纤维蛋白溶解治疗之后。

Drugs covered by this patent

Patent Metadata

Patent number: CN101495468A
Jurisdiction: CN
Classification: —
Expires: 2009-07-29
Drug substance claim: No
Drug product claim: No
Assignee: Activesite Pharmaceuticals Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.